These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 5823753)
1. [A derivative of benzyl-amine in the therapy of respiratory diseases in children]. Gambi R; Ongaro F; Paoli R; Russo U Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753 [No Abstract] [Full Text] [Related]
2. [Clinical considerations on a recent preparation with bronchial secretolytic action]. Santilli E; Castellana G Minerva Med; 1969 Sep; 60(76):3583-93. PubMed ID: 5823755 [No Abstract] [Full Text] [Related]
3. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Ercillo L; Mollica G Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758 [No Abstract] [Full Text] [Related]
4. [Clinical trial of a new substance with secretolytic action]. BontĂ L Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813 [No Abstract] [Full Text] [Related]
5. Clinical experience with a new secretolytic drug. Villa R; Orlandini GC Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759 [No Abstract] [Full Text] [Related]
6. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Trombini V Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757 [No Abstract] [Full Text] [Related]
7. [Apropos of 27 patients treated with bisolvomycin]. Breuil K Bord Med; 1971 Sep; 4(9):2469-70. PubMed ID: 5123583 [No Abstract] [Full Text] [Related]
8. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies]. Carnimeo N; Fino E; Maiorano V; Marzullo F Minerva Med; 1969 Sep; 60(76):3557-64. PubMed ID: 5823750 [No Abstract] [Full Text] [Related]
9. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Brignani F; Cavalli A; Fabbri M; Melica A Minerva Med; 1969 Sep; 60(75):3545-8. PubMed ID: 5344814 [No Abstract] [Full Text] [Related]
10. [Effects of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on expectoration, respiratory function, hepatic and cardiac function of subjects with chronic bronchopneumopathies]. Scarpa GL; Malavasi A; Dimich D; Giraudi D Minerva Med; 1969 Sep; 60(76):3594-9. PubMed ID: 5823756 [No Abstract] [Full Text] [Related]
11. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies]. Baracco F; Repetto E; Giordano L Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811 [No Abstract] [Full Text] [Related]
12. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings]. Lenzini L; Barnabè R Minerva Med; 1969 Sep; 60(76):3580-2. PubMed ID: 5823754 [No Abstract] [Full Text] [Related]
13. [The acid-base balance and the expectorant effect of bisolvon in children]. Wilk F Wien Klin Wochenschr; 1972 Sep; 84(85):549-51. PubMed ID: 5056490 [No Abstract] [Full Text] [Related]
14. [The parenteral use of a derivative of benzylamine in the control of tracheobronchial patological secretions]. Bianchetti L; Chiri A Minerva Med; 1969 Sep; 60(75):3521-4. PubMed ID: 5344812 [No Abstract] [Full Text] [Related]
15. [Prolonged automatic respiration and bronchial obstruction. Experience with a new "expectorant" in a Resuscitation Department]. De Medici M; Del Vecchio PE Minerva Med; 1969 Sep; 60(76):3571-4. PubMed ID: 5823752 [No Abstract] [Full Text] [Related]
16. [Our clinical experience with a new antitussive secretolytic drug]. Cuocolo R; Jovino R; Tufano R; Triggiani E Minerva Med; 1969 Sep; 60(76):3565-70. PubMed ID: 5823751 [No Abstract] [Full Text] [Related]
17. [Respiratory complications after abdominal surgery: therapeutic and diagnostic value of bronchodilator-secretolytic-expectorant preoperative treatment]. Capria V; Quacquarelli O Minerva Med; 1969 Sep; 60(75):3549-56. PubMed ID: 5344815 [No Abstract] [Full Text] [Related]
19. [Bisolvon in the treatment of the tracheo-bronchial secretory syndrome of the laryngectomized]. Ameli M Minerva Med; 1969 Sep; 60(75):3503-8. PubMed ID: 5344810 [No Abstract] [Full Text] [Related]
20. [Clinical, respiratory functional, bacteriological and immunological observations on the use of Bisolvon]. Bernardini V; Camerota G; Baronti A; Curti PC Minerva Med; 1969 Sep; 60(75):3514-20. PubMed ID: 4186563 [No Abstract] [Full Text] [Related] [Next] [New Search]